Oruka Therapeutics (DE:HQ1)
FRANKFURT:HQ1
Summary of all the Indicators
Overall Consensus
Buy
15Bullish
1Neutral
5Bearish
Technical Analysis Consensus
Sell
3Bullish
1Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Oruka Therapeutics’s (HQ1) Moving Averages Convergence Divergence (MACD) indicator is 3.83, suggesting Oruka Therapeutics is a Sell.
Oruka Therapeutics’s (HQ1) 20-Day exponential moving average is 36.61, while Oruka Therapeutics’s (HQ1) share price is €54.5, making it a Buy.
Oruka Therapeutics’s (HQ1) 50-Day exponential moving average is 32.13, while Oruka Therapeutics’s (HQ1) share price is €54.5, making it a Buy.
Oruka Therapeutics (HQ1) Pivot Points
Classic
42.40
42.60
43.00
43.20
43.60
43.80
44.20
Fibonacci
42.60
42.83
42.97
43.20
43.43
43.57
43.80
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Oruka Therapeutics (HQ1) Moving Averages
MA5
41.96Buy
42.96Buy
MA10
38.88Buy
39.99Buy
MA20
35.24Buy
36.61Buy
MA50
30.78Buy
32.13Buy
MA100
27.97Buy
28.32Buy
MA200
21.51Buy
22.15Buy
Oruka Therapeutics’s (HQ1) 10-Day exponential moving average is 39.99, while Oruka Therapeutics’s (HQ1) share price is €54.5, making it a Buy.
Oruka Therapeutics’s (HQ1) 100-Day exponential moving average is 28.32, while Oruka Therapeutics’s (HQ1) share price is €54.5, making it a Buy.
Oruka Therapeutics’s (HQ1) stock price is €54.5 and Oruka Therapeutics’s (HQ1) 50-day simple moving average is 30.78, creating a Buy signal.
Oruka Therapeutics’s (HQ1) stock price is €54.5 and Oruka Therapeutics’s (HQ1) 100-day simple moving average is 27.97, creating a Buy signal.
Oruka Therapeutics’s (HQ1) stock price is €54.5 and Oruka Therapeutics’s (HQ1) 200-day simple moving average is 21.51, creating a Buy signal.
Oruka Therapeutics (HQ1) Technical Indicators
RSI (14)
79.76
Sell
STOCH (9,6)
100.00
Sell
STOCHRSI (14)
100.00
Sell
MACD (12,26)
3.83
Sell
ADX (14)
29.19
Neutral
Williams %R
0.00
Sell
CCI (14)
209.64
Sell
ATR (14)
1.69
-
Ultimate Oscillator
85.71
Buy
ROC
41.18
Buy
Oruka Therapeutics’s (HQ1) Relative Strength Index (RSI) is 79.76, creating a Sell signal.
Oruka Therapeutics’s (HQ1) Trend Strength Indicator (ADX) is 29.19, creating a Neutral signal.
Oruka Therapeutics’s (HQ1) Commodity Channel Index (CCI) is 209.64, creating a Sell signal.
Oruka Therapeutics’s (HQ1) Price Rate of Change (ROC) is 41.18, creating a Buy signal.
FAQ
Is HQ1 a Buy, Hold, or Sell?
Based on HQ1’s technical indicators, HQ1 is a Buy.
What is HQ1’s RSI (14)?
HQ1’s RSI (14) is 79.76, which suggests HQ1 is a Sell.
What is HQ1’s MACD?
HQ1’s MACD is 3.83, which suggests HQ1 is a Sell.
What is HQ1’s 5-day moving average?
HQ1’s 5-day moving average is 41.96, which suggests HQ1 is a Buy.
What is HQ1’s 20-day moving average?
HQ1 20-day moving average is 35.24, which suggests HQ1 is a Buy.
What is HQ1’s 50-day moving average?
HQ1’s 50-day moving average is 30.78, which suggests HQ1 is a Buy.
What is HQ1’s 200-day moving average?
HQ1’s 200-day moving average is 21.51, which suggests HQ1 is a Buy.
What is HQ1’s Williams % R (14)?
HQ1’s Williams % R (14) is 0.00, which suggests HQ1 is a Sell.
What is HQ1’s CCI (14)?
HQ1’s CCI (14) is 209.64, which suggests HQ1 is a Sell.
What is the share price of Oruka Therapeutics?
Oruka Therapeutics's share price is N/A€.